FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to new 3-benzofuranyl-indol-2-one-3-acetamidopiperazine derivatives of formula
,
wherein: R1 means hydrogen atom; R2, R3, R4 are identical or different, found in any accessible position of phenyl nucleus; they independently mean hydrogen atom and halogen atom; R5 and R6 are identical or different, mean hydrogen atom, (C1-6) alkyl group; R7 means (C1-6) alkyl group; R8 and R9 found in any accessible position of piperazine nucleus, mean hydrogen atom, or (C1-6)alkyl group; at least one of R8 and R9 is differed from H; n means 1; which are present in the form of a base or an acid addition salt, as well as to methods for preparing these compounds, a therapeutic agent or a based pharmaceutical composition for treating obesity, diabetes, appetite disorder and overweight and to therapeutic use of these compounds.
EFFECT: preparing the compounds for treating obesity, diabetes, appetite disorder and overweight and to therapeutic use of these compounds.
10 cl, 3 ex
Title | Year | Author | Number |
---|---|---|---|
3-BENZOFURANYLINDOL-2-ONE DERIVATIVES SUBSTITUTED IN POSITION 3, PREPARING AND USING THEM IN THERAPY | 2010 |
|
RU2542991C2 |
CANCER CHEMOTHERAPY USING AZABICYCLO COMPOUND | 2018 |
|
RU2821034C2 |
DERIVATIVES OF N-(1,5-DIPHELYL-1H-PYRAZOL-3-YL)SULPHONAMIDE WITH AFFINITY TO CB RECEPTORS | 2005 |
|
RU2366657C2 |
(AZA)INDOLE-, BENZOTHIOPHENE- AND BENZOFURAN-3-SULPHONAMIDES | 2017 |
|
RU2767904C2 |
THIOPYRIDINES USED FOR CONTROL OF HELICOBACTER BACTERIA | 1995 |
|
RU2142459C1 |
PYRAN DERIVATIVES, METHOD FOR PREPARING AND USING THEM IN PERFUMERY AND FOR AROMATISATION | 2007 |
|
RU2459816C2 |
PYRIDOINDOLONE DERIVATIVES SUBSTITUTED IN POSITION 6, THEIR OBTAINING AND APPLICATION IN THERAPY | 2005 |
|
RU2364595C2 |
INHIBITORS OF BACTERIAL GYRASE AND THEIR APPLYING | 2001 |
|
RU2262932C2 |
PYRROLO-PYRROLE COMPOSITIONS AS ACTIVATORS OF PYRUVATE KINASE (PKR) | 2018 |
|
RU2736217C2 |
NOVEL COMPOUNDS AND USE THEREOF IN THERAPY | 2004 |
|
RU2412190C2 |
Authors
Dates
2015-02-27—Published
2010-02-09—Filed